Results 11 to 20 of about 768,821 (259)

Transvalvular mitral regurgitation following mitral valve replacement a diagnostic dilemma

open access: yesAnnals of Cardiac Anaesthesia, 2015
After mitral valve replacement with a prosthetic valve, the valve should be competent and there should not be any residual prosthetic valve regurgitation. Transvalvular residual prosthetic valve regurgitation are difficult to diagnose and quantify.
U S Dinesh Kumar   +3 more
doaj   +2 more sources

Effect of concurrent mitral valve surgery for secondary mitral regurgitation upon mortality after aortic valve replacement or coronary artery bypass surgery

open access: yesFrontiers in Cardiovascular Medicine, 2023
ObjectivesIt is uncertain whether concurrent mitral valve repair or replacement for moderate or greater secondary mitral regurgitation at the time of coronary artery bypass graft or aortic valve replacement surgery improves long-term survival ...
Shyamal R. Asher   +13 more
doaj   +1 more source

Redo Mitral Valve Replacement After Valve-in-Valve Transcatheter Mitral Valve Replacement

open access: yesCureus, 2023
The rising preference for percutaneous mitral valve-in-valve replacement (ViV TMVR) over redo surgical mitral valve replacement (MVR) is primarily due to its reduced bleeding risk. This report details a bloodless redo MVR performed for mitral stenosis post-ViV TMVR.
Tsukioka, Yusuke, Jeevanandam, Valluvan
openaire   +2 more sources

Resolution of severe secondary mitral valve regurgitation following aortic valve replacement in infective endocarditis [PDF]

open access: yes, 2021
We present the case of a patient with infective endocarditis anesthetized for replacement of severely regurgitant aortic valve. Intraoperative transesophageal echocardiography revealed a new diagnosis of severe secondary mitral regurgitation.
Bruelisauer, Thomas   +11 more
core   +2 more sources

Computed Tomography Planning for Transcatheter Mitral Valve Replacement

open access: yesStructural Heart, 2022
Transcatheter mitral valve replacement (TMVR) is a rapidly evolving treatment for mitral regurgitation. As with transcatheter aortic valve replacement, multidetector computed tomography analysis plays a central role in defining the candidacy, device ...
Go Hashimoto, MD   +10 more
doaj   +1 more source

Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease

open access: yesUS Cardiology Review, 2021
Delivery of electrosurgery energy through catheters and guidewires enables interventionists to ‘cut’ through obstructive intravascular lesions or across cardiac chambers.
Jaffar M Khan   +9 more
doaj   +1 more source

Treatment of More Than Moderate Ischemic Mitral Regurgitation in Patients Undergoing Left Ventricular Reconstruction

open access: yesCardiology Discovery, 2023
Objective:. While evidence-based clinical guidelines recommend chordal-sparing mitral valve replacement, rather than mitral valve repair, in patients with severe ischemic mitral regurgitation (IMR) undergoing coronary artery bypass grafting, there are no
Xieraili Tiemuerniyazi   +4 more
doaj   +1 more source

Structure-function relationships in the aortic valve [PDF]

open access: yes, 2012
PhDGlobally, heart valve dysfunction constitutes a large portion of the cardiovascular disease load, causing high rates of mortality in European and industrialized countries.
Anssari-Benam, Afshin
core   +4 more sources

Homograft Replacement of the Mitral Valve [PDF]

open access: yesCirculation, 1968
Replacement of the mitral valve with an aortic valve homograft has become feasible. Clinical and hemodynamic assessments of eight patients who received the new homograft were made from 3 to 6 months following surgery. Marked improvement was reported by six patients and mild to moderate improvement by two.
R E, Gianelly   +4 more
openaire   +2 more sources

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

open access: yesHepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy